Skip to Content

Nevirapine Teva

Licence status
Withdrawn: 06/03/2023
Active substances
Nevirapine
Dosage Form
Tablet
Licence number
EU/1/09/598/1-4
Licence holder
Teva Pharma B.V.

Licence information

ATC code
J05AG Non-nucleoside reverse transcriptase inhibitors, J05AG01 nevirapine
Legal supply status
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Conditions of Licence
Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
30/11/2009